Failure of estrogen plus progestin therapy for prevention

JAMA. 2002 Jul 17;288(3):366-8. doi: 10.1001/jama.288.3.366.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Breast Neoplasms / epidemiology
  • Breast Neoplasms / prevention & control
  • Coronary Disease / epidemiology
  • Coronary Disease / prevention & control*
  • Estrogen Replacement Therapy* / adverse effects
  • Estrogens, Conjugated (USP) / adverse effects
  • Estrogens, Conjugated (USP) / therapeutic use
  • Female
  • Humans
  • Medroxyprogesterone Acetate / adverse effects
  • Medroxyprogesterone Acetate / therapeutic use
  • Postmenopause
  • Progesterone Congeners / adverse effects
  • Progesterone Congeners / therapeutic use
  • Risk

Substances

  • Estrogens, Conjugated (USP)
  • Progesterone Congeners
  • Medroxyprogesterone Acetate